Xi Yang

Department Of Pharmacology And Tianjin Key Laboratory Of Inflammation Biology
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Rebastinib inhibits cerebral cavernous malformation in a chronic mouse model.

Rebastinib inhibits cerebral cavernous malformation in a chronic mouse model.

Journal: European journal of pharmacology

Published: March 31, 2026

Knockin expression of human ADAMTS5 impairs cardiovascular development and aggravates cerebral cavernous malformations in mice.

Knockin expression of human ADAMTS5 impairs cardiovascular development and aggravates cerebral cavernous malformations in mice.

Journal: Disease models & mechanisms

Published: September 15, 2025

Epicardial CCM2 Promotes Cardiac Development and Repair Via its Regulation on Cytoskeletal Reorganization.

Epicardial CCM2 Promotes Cardiac Development and Repair Via its Regulation on Cytoskeletal Reorganization.

Journal: JACC. Basic to translational science

Published: January 03, 2023

Role of pericytes in the development of cerebral cavernous malformations.

Role of pericytes in the development of cerebral cavernous malformations.

Journal: iScience

Published: July 05, 2022

Cerebral cavernous malformation development in chronic mouse models driven by dual recombinases induced gene deletion in brain endothelial cells.

Cerebral cavernous malformation development in chronic mouse models driven by dual recombinases induced gene deletion in brain endothelial cells.

Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Published: June 10, 2022

Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation.

Release of STK24/25 suppression on MEKK3 signaling in endothelial cells confers cerebral cavernous malformation.

Journal: JCI insight

Published: March 29, 2022

CCM2L (Cerebral Cavernous Malformation 2 Like) Deletion Aggravates Cerebral Cavernous Malformation Through Map3k3-KLF Signaling Pathway.

CCM2L (Cerebral Cavernous Malformation 2 Like) Deletion Aggravates Cerebral Cavernous Malformation Through Map3k3-KLF Signaling Pathway.

Journal: Stroke

Published: March 04, 2021

Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican.

Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican.

Journal: The Journal of experimental medicine

Published: January 27, 2020

Influence of Randomness in Rubber Materials Parameters on the Reliability of Rubber O-Ring Seal.

Influence of Randomness in Rubber Materials Parameters on the Reliability of Rubber O-Ring Seal.

Journal: Materials (Basel, Switzerland)

Published: April 05, 2019

Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.

Ponatinib (AP24534) inhibits MEKK3-KLF signaling and prevents formation and progression of cerebral cavernous malformations.

Journal: Science advances

Published: May 03, 2018

An Alternative Lifetime Model for White Light Emitting Diodes under Thermal⁻Electrical Stresses.

An Alternative Lifetime Model for White Light Emitting Diodes under Thermal⁻Electrical Stresses.

Journal: Materials (Basel, Switzerland)

Published: April 12, 2018

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model.

Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model.

Journal: Journal of visualized experiments : JoVE

Published: September 12, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026